Stephen Mayo - Director at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ALLO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Stephen Mayo - trading volume in the past year for Allogene Therapeutics, Inc.

Holdings reported by Stephen Mayo for Allogene Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 25,328 $80.4 K $3.17 Aug 7, 2023 Direct
Stock Option (Right to buy) 191,082 Jun 5, 2024 Direct Common Stock

Transactions reported by Stephen Mayo for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership